\r\n \r\n
Had not heard of it but here it is. \n
\n
https://www.gcmaf.eu/info/\n
\n
GcMAF - treatment for cancer, aids and immune diseases \n
\n
It is our immune system that prevents and cures cancer\n
A macrophage (purple) eats cancer cells The first research was published in 1993 and since then many papers have appeared indicating GcMAF rebuilds the immune system, and the immune system then eradicated Cancer and HIV.
\nDr. Nobuto Yamamoto in Philadelphia was the first, but hundreds of scientists have now worked on this and related projects.
\n
How does GcMAF work?\nIn a healthy person your GcMAF instructs macrophages in your bloodstream to scour our bodies and kill malignancies. But malignant cells like cancer send out an enzyme called Nagalase that neutralises your GcMAF; so the macrophages never get the message to go into action – in this way cancer suppresses the immune system, and cancer cells grow unchecked. To reverse this, we make GcMAF outside the body, and it is injected once a week for 25 weeks for early cancers, a year for late stage cancers. (Encapsulated tumours require additional treatment.)
\n
\nWe are the main supplier for research universities, together with more than 50 cancer clinics and doctors.
\n
\nIn its role of immune system regulator, research shows GcMAF can reverse other diseases that attack the immune system like Autism, CFS, XMRV, Lyme disease, Aids, HIV, Fibromyalgia (all of which we\'ve begun to have success with ourselves), osteoporosis, Hodgkin’s, Lupus, MS, Parkinson’s, various bacterial and viral infections and various types of Immune dysfunction.
\n
\n
Small pre-clinical trials to build the case are again taking place.\n
Our GcMAF destroying human cancer cells for 72 hours. At 100ng/ml, panel D, cells show an irregular shape and size. They are significantly smaller as if processes of shrinkage had occurred. Cells appear inhomogeneous and both cytoplasm and nucleus appear irregular as if fragmented. Numerous cellular debris can be observed as well as apoptotic bodies. Clusters are much fewer in number and their borders appear less defined. Those diagnosed with any of these illnesses, and who have done their own research on it, are invited to respond. We ask for a copy of diagnostic information and update reports from a physician during and after treatments, to help build the case that GcMAF is a cure for various illnesses, which will help to make it available to the public. Participants are free to stop at any time, and we can recommend a Doctor if required.
\n
\n
What have we learned?\nDr Yamamoto carefully selected his trials: he took fit people with in the early stages of cancer and HIV, and reported 100% success, with no recurrence after many years. He did not attempt to cure people with large tumours.
\n
\nOur trials are quite different: most people are over 50, some over 80, with advanced or terminal cancers, with significant tumour mass.
\nWe appear to have had excellent results in 20 percent of cases, and we think we have learned enough to take that figure up to 50% in this 2011 round of trials.
\n
\nGcMAF needs normal levels of vitamin D to function strongly, and those participants can see significant tumour shrinkage in 8 weeks. But even in low responders, GcMAF appears to stop the advance of cancer.
\n
\nWe have probably proved GcMAF can work for people up to age 90, with terminal stage 4 cancer, and can completely destroy large tumour mass. See "Patients on GcMAF" on the left.
\n
\nRemember, GcMAF requires normal levels of vitamin D to work properly. So far those patients who in 8 weeks are cured of symptoms, or whose tumour mass drops significantly, all take 4000 IU plus of vitamin D, and outdoor exercise, perhaps a 40 minute walk each day.
\n
\nHIV participants who also take 4000IU plus of vitamin D daily can expect to see nagalese drop to normal after 16 weeks.
\n
\nBut the beauty of using your own immune system to cure cancer is that it remembers how to defeat it for the rest of your life: it doesn\'t come back. And unlike chemotherapy, the side effects are trivial
.\n
\nWe are now beginning new preclinical trials, and have GcMAF available. See "Buy GcMAF here," top left. If you have questions, click "Contact" at the top to send us an email, or call our contact person David Noakes +44 7781 411 737.\r\n
\r\n\r\n GcMAF\r\n 
\r\n \r\n \r\n \r\n \r\n \r\n \r\n \r\n \r\n \r\n \r\n <!-' + '- / controls -' + '->\r\n 
\r\n\r\n\r\n \r\n \r\n 
\r\n\r\n \r\n \r\n 
\r\n
Threaded Mode
